ClinVar Miner

Submissions for variant NM_032043.3(BRIP1):c.2902A>G (p.Lys968Glu)

gnomAD frequency: 0.00001  dbSNP: rs587782679
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000132105 SCV000187170 uncertain significance Hereditary cancer-predisposing syndrome 2022-03-31 criteria provided, single submitter clinical testing The p.K968E variant (also known as c.2902A>G), located in coding exon 18 of the BRIP1 gene, results from an A to G substitution at nucleotide position 2902. The lysine at codon 968 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Invitae RCV000470512 SCV000547382 uncertain significance Familial cancer of breast; Fanconi anemia complementation group J 2023-12-08 criteria provided, single submitter clinical testing This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 968 of the BRIP1 protein (p.Lys968Glu). This variant is present in population databases (rs587782679, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with BRIP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 142732). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The glutamic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Mendelics RCV000709534 SCV000839360 uncertain significance Fanconi anemia complementation group J 2018-07-02 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000132105 SCV000903284 likely benign Hereditary cancer-predisposing syndrome 2016-10-31 criteria provided, single submitter clinical testing
Mendelics RCV000989989 SCV001140751 uncertain significance Familial cancer of breast 2019-05-28 criteria provided, single submitter clinical testing
Sema4, Sema4 RCV000132105 SCV002533656 uncertain significance Hereditary cancer-predisposing syndrome 2021-11-01 criteria provided, single submitter curation
Baylor Genetics RCV000989989 SCV004217052 uncertain significance Familial cancer of breast 2023-07-14 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.